White Paper
Living with COVID-19: six months since the start of the pandemic
Sep 02, 2020

IQVIA's second report in a special white paper series provides a longitudinal update on the impact of COVID-19 on the Australian healthcare industry, six months since the start of the pandemic. The analysis and perspectives leverage IQVIA data assets and analytic expertise, as well as primary research with healthcare professionals and industry experts.

It provides a detailed focus on:

  • Demand for prescription medicines and the impact on critical therapeutic areas
  • Evolution in the consumption of non-prescription health products including export and e-commerce trends
  • Impact of COVID-19 on pharmaceutical promotional deployment and the evolving needs of healthcare
    professionals
  • Outlook for clinical development and impacts for clinical research operations and evidence generation
Contact Us